MFN2 and Alzheimer disease: The results indicated that the levels of Drp1, OPA1, Mfn1, and Mfn2 were significantly reduced in the hippocampus of AD patients, which is consistent with the abnormal changes in mitochondrial dynamics observed in AD (Wang et al., 2009).